Improving access to pharmaceuticals in Brazil and Argentina

Health Policy and Planning

Volumn 21, Issue 2, 2006, Pages 123-131

  Homedes, Núria ^a   Ugalde, Antonio ^b  

^a UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

^b UNIVERSITY OF TEXAS AT AUSTIN   (United States)

Author keywords

AIDS HIV; Argentina; Brazil; Essential drugs; Pharmaceutical interventions; Remediar

Indexed keywords

ANTIRETROVIRUS AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARGENTINA; ARTICLE; BRAZIL; CLINICAL TRIAL; HEALTH PROGRAM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MEDICAL LITERATURE; POLITICS;

ARGENTINA; BRAZIL; DRUG COSTS; HEALTH SERVICES ACCESSIBILITY; HIV INFECTIONS; HUMANS; PHARMACEUTICAL PREPARATIONS; POVERTY;

EID: 32244446145     PISSN: 02681080     EISSN: 14602237     Source Type: Journal    
DOI: 10.1093/heapol/czj011     Document Type: Article

References (39)

1. Anonymous. 2003. El 50% de los bolivianos no tiene acceso a medicamentos. Los Tiempos, March 6, p. 5. Available at [http:// www.boletinfarmacos.org], 6 (3), June 2003, p. 36.
2. Bermudez JAZ, Oliveira MA, Andrade de Oliveira E. 2004. Expanding access to essential medicines in Brazil: recent regulation and public policies. In: Bermudez JAZ, Oliveira MA (eds). Intellectual property in the context of the WTO TRIPS Agreement: challenges for public health. Rio de Janeiro: Fiocruz, p. 129-50.
3. Bernztein R, Monsalvo M. 2004. Análisis de los diagnósticos o problemas de salud. Boletín PROAPS-Remediar (Buenos Aires) 2: 11-14.
4. Casabal A, Cabanas M. 2004. El control social de Remediar. Dos años de aprendizaje y crecimiento. Boletín PROAPS-Remediar (Buenos Aires) 2: 17-19.
5. Cohen JC. 2000. Public policies in the pharmaceutical sector: a case study of Brazil. LCSHD Paper Series no 54. Washington DC: The World Bank.
6. Consejo Federal de Salud. 2004. Bases del plan federal de salud 2004-2007. Ministerio de Salud de la Nación de Argentina. Boletín PROAPS-Remediar (Buenos Aires) 2: 4-24.
7. Drug Utilization Research Group, Latin America (DURG-LA). 1997. Multicenter study on self-medication and self-prescription in six Latin American countries. Clinical Pharmacology and Therapeutics 61: 488-93.
8. Galvão J. 2002. Access to antiretroviral drugs in Brazil. The Lancet 360: 1862-65.
9. Haas N. 2003. Brazil receives accolades from comprehensive AIDS program. New York: Sexuality Information and Education Council of the United States. Policy Update, August. Available at: [http://www.siecus.org/policy/PUpdates/ pdate0071.html], accessed 14 November 2003.
10. Hacker MA, Petersen ML, Enriquez M, Bastos FI. 2004. Highly active antiretroviral therapy in Brazil: the challenge of universal access in a context of social inequality. Pan American Journal of Public Health 16: 78-83.
11. Harvard University, AIDS Care Teams. 2005. Brazil Team, São Paulo & Santos. Phase II and III - Research and Implementation: Enhanced Care for Women. Available at: [http://www.eci.harvard.edu/teams/brazil], accessed 17 February 2005.
12. Homedes N, Ugalde A. 2001. Improving the use of pharmaceuticals through patient and community interventions. Social Science and Medicine 51: 99-134.
13. Homedes N, Ugalde A. 2005. Multisource drug policies in Latin America: survey of 10 countries. Bulletin of the World Health Organization 83: 64-70.
14. Kaiser Daily HIV/AIDS Report. 2004. Brazil's National STD/AIDS Programme announces largest drug price reduction deals in five years. 20 January 2004. Available at: [http://www.kaisernetwork.org/daily_reports/print_report.cfm? DR_ID=21751&dr_cat=1] accessed 17 February 2005.
15. LatinSalud. 2005. Brasil gana premio por trabajo en Sida. LatinSalud.com, 31 August 2004. Available at: [http://www. latinsalud.com/articulos.10600.asp], accessed 17 February 2005.
16. Levi GC, Vitória MAA. 2002. Fighting against AIDS: the Brazilian experience. AIDS 16: 2373-83.
17. Leyva-Flores R, Brofman M, Erviti-Erice J. 2000. Simulated clients in drugstores: prescriptive behaviour of drugstore attendants. Journal of Social and Administrative Pharmacy 17: 151-8.
18. López Linares R. 2001. La lucha por el acceso a medicamentos esenciales. Boletín Fármacos 4: 38-45.
19. Ministerio da Saúde. 2002. + Response (The experience of the Brazilian Aids Programme). Brasilia: Ministerio da Saúde.
20. Ministerio de Salud de La Nación de Argentina. 2002. Remediar. Informe de Situación. Buenos Aires: Ministerio de Salud de la Nación, 30 de noviembre.
21. Ministerio de Salud de La Nación de Argentina. 2003. Remediar. Informe de Situación. Buenos Aires: Ministerio de Salud de la Nación, mayo.
22. Ministerio de Salud de la Nación de Argentina. 2004. PROAPS-Remediar. Control Social Directo. Buenos Aires: Ministerio de Salud de la Nación.
23. Oliveira Cruz V, Kowalski J, McPake B. 2004. Viewpoint: The Brazilian HIV/AIDS 'success story' - can others do it? Tropical Medicine and International Health 9: 292-7.
24. Ortells P. 2003. Brazil: a model response to AIDS. Silver City, NM: International Relations Center (IRC) Americas Program. Special report, April. Available at: [http://www.americaspolicy. org], accessed 6 January 2004.
25. Oxfam GB. 2001. Drug companies vs. Brazil: the threat to public health. Oxford: Oxfam GB, May. Available at: [http:// www.oxfam.org.uk/what_we_do/ issues/health/downloads/ drugcomp_brazil.rtf], accessed 11 September 2003.
26. Paiva V, Ayres JR, Buchalla CM, Hearst N. 2002. Building partnerships to respond to HIV/AIDS: non-governmental organizations and universities. AIDS 16(Suppl. 3): S76-S82.
27. Perry G, Servén L. 2003. The anatomy of a multiple crisis. Why was Argentina special and what can we learn from it? Policy Research Working Paper no. 3081. Washington DC: The World Bank, June.
28. PROAPS. 2003a. Innovaciones en adquisiciones y evaluación del programa Remediar. Paper presented at Semana de Desarrollo Social, Inter-American Development Bank (IDB), Washington, DC, 3-5 November 2003.
29. PROAPS. 2003b. Remediar. Available at: [http://www.remediar. gov.ar/site/boletines.asp], accessed 2 December 2003.
30. Quesada C. 2002. Leadership, consensus and technology. With broad support from society, Brazil is improving the quality of life of HIV carriers. IDB America, 2002. Available at: [http:// www.iadb.org/idbamerica/English/FEB02E/ feb02e5.html], accessed 2 February 2003.
31. Reardon C. 2002. AIDS: How Brazil turned the tide. Can others emulate its success? Ford Foundation Report, Summer 2002. Available at: [http://www.fordfound.org/publications/ ff_report/view_ff_report_detail.cfm? report_index=352], accessed 17 February 2005.
32. Remediar. 2003. Reglamento de procedimientos par incumplimientos y penalidades. Buenos Aires: Ministerio de Salud de la Nación.
33. Remediar. 2004. Sugerencia de Operaciones. Área Programación. Evaluación del programa Remediar. Boletín PROAPS-Remediar (Buenos Aires) 2: 14-16.
34. Tobar F. 2002. Acceso a los medicamentos en Argentina: diagnóstico y alternatives. Boletín Fármacos 5: 35-45.
35. Tobar F. 2003. Un poderoso instrumento para mejorar la atención primaria. Boletín PROAPS-Remediar (Buenos Aires) 1: 1-2.
36. Tobar F. 2004a. Políticas para promoción del acceso a medicamentos: El caso del Programa Remediar de Argentina. Nota técnica de discusión de salud 2000/2004. Washington DC: Banco InterAmericano de Desarrollo Sostenible, Departamento de Desarrollo Sostenible, División de Programas Sociales, January.
37. Tobar F. 2004b. El programa Remediar en la política de salud: una estrategia en acción. Buenos Aires: Ministerio de la Nación de Argentina.
38. UNAIDS, PAHO. 2004. Brazil: Fact Sheets on HIV/AIDS Care and Treatment. Updated October 2004. Washington DC: Pan American Health Organization.
39. WHO. 2001. How to develop and implement a national drug policy. Second edition. Geneva: World Health Organization.